These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 16894293)

  • 21. Kaposi's sarcoma-associated herpesvirus transmission and primary infection.
    Bagni R; Whitby D
    Curr Opin HIV AIDS; 2009 Jan; 4(1):22-6. PubMed ID: 19339936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kaposi sarcoma-associated herpesvirus; human herpesvirus 8].
    Kemény L; Gyulani R; Kiss M; Dobozy A
    Orv Hetil; 1997 Apr; 138(16):979-83. PubMed ID: 9190549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
    Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
    Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular virology of Kaposi's sarcoma-associated herpesvirus.
    Moore PS; Chang Y
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):499-516. PubMed ID: 11313008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposi's sarcoma of the gastrointestinal tract: report of two cases and review of the literature.
    Kahl P; Buettner R; Friedrichs N; Merkelbach-Bruse S; Wenzel J; Carl Heukamp L
    Pathol Res Pract; 2007; 203(4):227-31. PubMed ID: 17379429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune evasion by Kaposi's sarcoma-associated herpesvirus.
    Coscoy L
    Nat Rev Immunol; 2007 May; 7(5):391-401. PubMed ID: 17457345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor.
    Burger M; Burger JA; Hoch RC; Oades Z; Takamori H; Schraufstatter IU
    J Immunol; 1999 Aug; 163(4):2017-22. PubMed ID: 10438939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KSHV/HHV8-associated intestinal Kaposi's sarcoma in patient with ulcerative colitis receiving immunosuppressive drugs: report of a case.
    Svrcek M; Tiret E; Bennis M; Guyot P; Fléjou JF
    Dis Colon Rectum; 2009 Jan; 52(1):154-8. PubMed ID: 19273971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes.
    Direkze S; Laman H
    Int J Exp Pathol; 2004 Dec; 85(6):305-19. PubMed ID: 15566428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients.
    Chandra A; Demirhan I; Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Linde A; Heiden T; Biberfeld P; Doerr HW; Cinatl J; Loewer J; Chandra P
    Anticancer Res; 2003; 23(1B):723-8. PubMed ID: 12680174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What's new in Kaposi's sarcoma research.
    Trethewey P
    STEP Perspect; 1997; 9(3):9-10. PubMed ID: 11364938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do viral chemokines modulate Kaposi's sarcoma?
    Dittmer D; Kedes DH
    Bioessays; 1998 May; 20(5):367-70. PubMed ID: 9670810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kaposi's sarcoma herpesvirus load in biopsies of cutaneous and oral Kaposi's sarcoma lesions.
    Pak F; Mwakigonja AR; Kokhaei P; Hosseinzadeh N; Pyakurel P; Kaaya E; Bogdanovic G; Selivanova G; Biberfeld P
    Eur J Cancer; 2007 Aug; 43(12):1877-82. PubMed ID: 17627810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First report of Kaposi's sarcoma-associated herpesvirus DNA sequences from Cuban Kaposi's sarcoma patients without HIV infection.
    Kourí V; Martínez PA; Acosta B; Rodríguez ME; Blanco O; Capó V; González RL; Viera J; Hengge UR
    AIDS; 2007 Oct; 21(15):2113-5. PubMed ID: 17885307
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus.
    Dittmer DP; Krown SE
    Curr Opin Oncol; 2007 Sep; 19(5):452-7. PubMed ID: 17762570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Kaposi's disease].
    Lebbé C
    Rev Prat; 1999 Apr; 49(8):843-7. PubMed ID: 10337197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.
    Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC
    J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaposi's sarcoma biology.
    Boshoff C
    IUBMB Life; 2002; 53(4-5):259-61. PubMed ID: 12121006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kaposi's sarcoma].
    Remenyik E; Juhász A; Hunyadi J
    Orv Hetil; 2005 Oct; 146(40):2047-55. PubMed ID: 16259333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.